Literature DB >> 26846366

Choosing exercise or pharmacologic stress imaging, or exercise ECG testing alone: How to decide.

Jorge A Gonzalez1, George A Beller2.   

Abstract

Mesh：

Year:  2016        PMID： 26846366     DOI： 10.1007/s12350-016-0409-3

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  16 in total

1.  Comparison of the current reasons for undergoing pharmacologic stress during echocardiographic and radionuclide stress testing.

Authors:  Edgar Argulian; Jose Ricardo F Po; Seth Uretsky; Kiran K Kommaraju; Suketukumar Patel; Vikram Agarwal; Randy Cohen; Alan Rozanski
Journal:  J Nucl Cardiol       Date:  2016-02-24       Impact factor: 5.952

2.  Trends in noninvasive testing for coronary artery disease: less exercise, less information.

Authors:  S Michael Gharacholou; Patricia A Pellikka
Journal:  Am J Med       Date:  2014-09-03       Impact factor: 4.965

3.  Clinical role of the Duke Activity Status Index in the selection of the optimal type of stress myocardial perfusion imaging study in patients with known or suspected ischemic heart disease.

Authors:  Lawrence Phillips; Jing Wa Wang; Brad Pfeffer; Eugenia Gianos; Daniel Fisher; Leslee J Shaw; Jennifer H Mieres
Journal:  J Nucl Cardiol       Date:  2011-10-05       Impact factor: 5.952

4.  Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients.

Authors:  A S Iskandrian; J Heo; B Kong; E Lyons
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

5.  Exercise capacity and mortality among men referred for exercise testing.

Authors:  Jonathan Myers; Manish Prakash; Victor Froelicher; Dat Do; Sara Partington; J Edwin Atwood
Journal:  N Engl J Med       Date:  2002-03-14       Impact factor: 91.245

6.  Achieving an exercise workload of > or = 10 metabolic equivalents predicts a very low risk of inducible ischemia: does myocardial perfusion imaging have a role?

Authors:  Jamieson M Bourque; Benjamin H Holland; Denny D Watson; George A Beller
Journal:  J Am Coll Cardiol       Date:  2009-08-04       Impact factor: 24.094

7.  Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial.

Authors:  M I Ross; E Wu; J T Wilkins; D Gupta; S Shen; D Aulwes; K Montero; T A Holly
Journal:  J Nucl Cardiol       Date:  2013-02-13       Impact factor: 5.952

8.  Asystole following regadenoson infusion in stable outpatients.

Authors:  Jeffrey Rosenblatt; Deirdre Mooney; Timothy Dunn; Mylan Cohen
Journal:  J Nucl Cardiol       Date:  2014-05-31       Impact factor: 5.952

9.  Prognostic implications of myocardial perfusion single-photon emission computed tomography in the elderly.

Authors:  Rory Hachamovitch; Xingping Kang; Aman M Amanullah; Aiden Abidov; Sean W Hayes; John D Friedman; Ishac Cohen; Louise E J Thomson; Guido Germano; Daniel S Berman
Journal:  Circulation       Date:  2009-11-16       Impact factor: 29.690

10.  Safety and feasibility of regadenoson use for suboptimal heart rate response during symptom-limited standard Bruce exercise stress test.

Authors:  Sara L Partington; Viswanatha Lanka; Jon Hainer; Ron Blankstein; Hicham Skali; Daniel E Forman; Marcelo F Di Carli; Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2012-05-08       Impact factor: 5.952
View more
  4 in total

Review 1.  Quantification of PET Myocardial Blood Flow.

Authors:  Matthieu Pelletier-Galarneau; Patrick Martineau; Georges El Fakhri
Journal:  Curr Cardiol Rep       Date:  2019-02-28       Impact factor: 2.931

2.  The prognostic implications of ST-segment and T-wave abnormalities in patients undergoing regadenoson stress SPECT myocardial perfusion imaging.

Authors:  Muhammad Shahzeb Khan; Abdul Wahab Arif; Rami Doukky
Journal:  J Nucl Cardiol       Date:  2020-10-08       Impact factor: 5.952

3.  Comparison of myocardial blood flow and flow reserve with dobutamine and dipyridamole stress using rubidium-82 positron emission tomography.

Authors:  Matthieu Pelletier-Galarneau; Paola Ferro; Samuel Patterson; Terrence D Ruddy; Rob S Beanlands; Robert A deKemp
Journal:  J Nucl Cardiol       Date:  2020-05-24       Impact factor: 5.952

Review 4.  Current approach to the diagnosis of atherosclerotic coronary artery disease: more questions than answers.

Authors:  Adam J Nelson; Maddalena Ardissino; Peter J Psaltis
Journal:  Ther Adv Chronic Dis       Date:  2019-11-01       Impact factor: 5.091
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.